RxDoctor Payments Data

Amir Bajoghli, MD

MOHS-Micrographic Surgery · Mc Lean, VANPI 1275586190

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,806 of the $3,676 with a category attached, or 76.3%. It is spread thinly across 25 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.

$3,676in general payments, 2019–2025

Across 107 payments — averaging $34.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$780
  • Galderma Laboratories, L.p.$470
  • AbbVie$363
  • Johnson & Johnson$332
  • Novartis$203
  • Incyte Corporation$161
  • plus $1K from 19 others
$5,160in research payments, 2019–2025

Across 5 payments — averaging $1032.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$5K

What the payments were for

  • Food & beverage$2,80676%
  • Education$1634%
  • Other$70719%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,676 in reported general payments places this provider in the 75th percentile of 36 mohs-micrographic surgery providers in Virginia.

See all mohs-micrographic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$1,480,921
Medicare patients
828
Services billed
5,393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PanretinAlitretinoin13$75,140
Mupirocin289$2,501
Imiquimod12$2,124
Clobetasol Propionate26$1,302
CiclopiroxCiclopirox Olamine13$933
Halobetasol Propionate13$897
Tretinoin14$773
Doxycycline Monohydrate56$731
Ketoconazole32$683
Gentamicin Sulfate13$662
Ammonium Lactate30$613
Metronidazole13$431
Triamcinolone Acetonide25$285
Doxycycline Hyclate43$228
Hydrocortisone24$116

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Mc Lean

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →